Almonds With/Without Chocolate May Improve Lipid ProfilesLast Updated: December 01, 2017. Eating raw almonds, dark chocolate, and cocoa can significantly improve lipid profiles of overweight and obese people, according to a small study published online Nov. 29 in the Journal of the American Heart Association.
FRIDAY, Dec. 1, 2017 (HealthDay News) -- Eating raw almonds, dark chocolate, and cocoa can significantly improve lipid profiles of overweight and obese people, according to a small study published online Nov. 29 in the Journal of the American Heart Association.
Yujin Lee, Ph.D., from Pennsylvania State University in Hershey, and colleagues assessed the individual and combined effects of consumption of dark chocolate and cocoa and almonds on markers of coronary heart disease risk as part of a feeding trial conducted with 48 overweight and obese individuals aged 30 to 70 years. The four isocaloric, weight maintenance diets included the average American diet, almonds, cocoa powder and dark chocolate, or all three foods (CHOC+ALD).
The researchers found that total cholesterol, non-high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol were all lower after the almond diet (P < 0.05), compared with the average American diet. Apolipoprotein B decreased by 5 percent with the CHOC+ALD compared with the average American diet. The almond diet showed a greater drop in large buoyant low-density lipoprotein particles (P = 0.04), whereas the CHOC+ALD had a greater decline in small dense low-density lipoprotein particles (P = 0.04), compared with the average American diet. No significant differences were seen in vascular health and oxidative stress between the diets.
"People are allowed to have about 270 discretionary calories a day, and when foods like almonds, dark chocolate, and cocoa are consumed together as a discretionary food, they confer health benefits unlike other discretionary foods such as frosted donuts," a coauthor said in a statement.
Several authors disclosed financial ties to The Hershey Company and the Almond Board of California, both of which funded the study.
|Previous: Study IDs Clinical Factors Tied to Free Tissue Transfer Reoperation||Next: FDA Approves Biosimilar Ogivri for Breast, Stomach Cancers|
Reader comments on this article are listed below. Review our comments policy.